PUBLISHER: iData Research Inc. | PRODUCT CODE: 1680159
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1680159
The global robotic-assisted neurosurgery system market was valued at approximately $130 million in 2024 and is projected to grow at a CAGR of 14.5%, reaching less than $330 million by 2031.
The market is segmented into:
Market Insights & Data Coverage
Market Trends & Growth Drivers
* Minimally invasive procedures, leading to:
* Higher accuracy
* Shorter recovery times
* Fewer complications & revisions
* Lower hospital stays and costs
* High system costs & training requirements
* Learning curve for surgeons - mastery requires extensive training and multiple procedures.
* Surgeon adoption rate may limit growth in certain regions.
Geographic Trends & Growth Projections
Market Share Insights
Leading Competitors & Key Developments
1 Zimmer Biomet - Market Leader
* Offers ROSA(R) ONE Brain, part of the ROSA(R) robotics portfolio for neurosurgery.
2 Synaptive Medical - Second-Largest Player
* Provides the Brightmatter(TM) product line and Modus V(TM), a robotic microscope.
* The Brightmatter(TM) line includes Brightmatter(TM) Plan and Guide, used alongside Modus V(TM).
3 Medtronic - Third-Largest Player
* Offers Stealth Autoguide(TM), a cranial robotic platform.
* FDA-approved in December 2019 and actively expanding market reach.
Market Segmentation Summary
Global Research Scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia-Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative Coverage
Qualitative Coverage
Data Sources